We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
Bogdan Cristian Dinu
Apr 03, 2021
Trastuzumab +\- Pertuzumab without chemo prolonging neoadjuvant therapy for six cycles .Radiotherapy after both supraclavicullar clearance posibile .Endocrine therapy related with imunochemistry notation after tumor resection.
Ashraf Elzayat
Apr 09, 2021
I have a very similar case, Er, Pr weak positive, Ger2 +ve. Complete clinical response after ONLY 4 CYCLES AC. starting Taxanes next, I plan surgery before I start Herceptin. If complete pathological response, might omit herceptin!!
mohamad kadri
Apr 09, 2021
The patient should be considered stage IV (none regional node mets) and treated by anti her2 (Trastuzumab +/_ Pertuzumab) till progression.
Local treatment (surgery +/_ RT) may be considered according to the local response.
Gabriele Dr.Doering
Apr 11, 2021
The same recommandation -like mohamad -also from me !
EMADMOHSEN EL-NASHAR
Apr 12, 2021
Her2/neu by FISH, PDL1 and BRCA 1/2, done or not?
Dr.kawyba A.A.A
Apr 12, 2021
her2 by FISH. What is the role of pdl1 in her2 positive breast cancer. Do you recommend surgery?
Rham Zaki
Oct 09, 2021
Same as mohamed kadri
Apr 18, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
Bogdan Cristian Dinu
Apr 03, 2021
Ashraf Elzayat
Apr 09, 2021
mohamad kadri
Apr 09, 2021
Gabriele Dr.Doering
Apr 11, 2021
EMADMOHSEN EL-NASHAR
Apr 12, 2021
Dr.kawyba A.A.A
Apr 12, 2021
Rham Zaki
Oct 09, 2021
Apr 18, 2024
Pending Moderator approval.